Neoadjuvant chemotherapy remodels the tumor immune microenvironment by increasing activated and cytotoxic T cell, decreasing B cells and macrophages in small cell lung cancer

J Transl Med. 2023 Sep 21;21(1):645. doi: 10.1186/s12967-023-04526-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Lung Neoplasms* / drug therapy
  • Macrophages
  • Neoadjuvant Therapy
  • Small Cell Lung Carcinoma* / drug therapy
  • T-Lymphocytes, Cytotoxic
  • Tumor Microenvironment